Cargando…

Novel Chikungunya Vaccine Candidate with an IRES-Based Attenuation and Host Range Alteration Mechanism

Chikungunya virus (CHIKV) is a reemerging mosquito-borne pathogen that has recently caused devastating urban epidemics of severe and sometimes chronic arthralgia. As with most other mosquito-borne viral diseases, control relies on reducing mosquito populations and their contact with people, which ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Plante, Kenneth, Wang, Eryu, Partidos, Charalambos D., Weger, James, Gorchakov, Rodion, Tsetsarkin, Konstantin, Borland, Erin M., Powers, Ann M., Seymour, Robert, Stinchcomb, Dan T., Osorio, Jorge E., Frolov, Ilya, Weaver, Scott C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145802/ https://www.ncbi.nlm.nih.gov/pubmed/21829348 http://dx.doi.org/10.1371/journal.ppat.1002142

Ejemplares similares

A Novel Live-Attenuated Vaccine Candidate for Mayaro Fever
por: Weise, William J., et al.
Publicado: (2014)

Chikungunya Virus 3′ Untranslated Region: Adaptation to Mosquitoes and a Population Bottleneck as Major Evolutionary Forces
por: Chen, Rubing, et al.
Publicado: (2013)

A Novel MVA Vectored Chikungunya Virus Vaccine Elicits Protective Immunity in Mice
por: Weger-Lucarelli, James, et al.
Publicado: (2014)

Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates
por: Strouts, Fiona R., et al.
Publicado: (2016)

Sequential Adaptive Mutations Enhance Efficient Vector Switching by Chikungunya Virus and Its Epidemic Emergence
por: Tsetsarkin, Konstantin A., et al.
Publicado: (2011)

Extended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated Chikungunya Vaccine Candidate
por: Plante, Kenneth S, et al.
Publicado: (2015)

Optimized production and immunogenicity of an insect virus-based chikungunya virus candidate vaccine in cell culture and animal models
por: Adam, Awadalkareem, et al.
Publicado: (2021)

Stability of Yellow Fever Virus under Recombinatory Pressure as Compared with Chikungunya Virus
por: McGee, Charles E., et al.
Publicado: (2011)

Immunogenicity and Efficacy of a Measles Virus-Vectored Chikungunya Vaccine in Nonhuman Primates
por: Rossi, Shannan L, et al.
Publicado: (2019)

Multi-peaked adaptive landscape for chikungunya virus evolution predicts continued fitness optimization in Aedes albopictus mosquitoes
por: Tsetsarkin, Konstantin A., et al.
Publicado: (2014)

Preclinical Evaluation of the Immunogenicity and Safety of an Inactivated Enterovirus 71 Candidate Vaccine
por: Hwa, Shi-Hsia, et al.
Publicado: (2013)

Epistatic Roles of E2 Glycoprotein Mutations in Adaption of Chikungunya Virus to Aedes Albopictus and Ae. Aegypti Mosquitoes
por: Tsetsarkin, Konstantin A., et al.
Publicado: (2009)

A Single Mutation in Chikungunya Virus Affects Vector Specificity and Epidemic Potential
por: Tsetsarkin, Konstantin A, et al.
Publicado: (2007)

Minimum infectious dose for chikungunya virus in Aedes aegypti and Ae. albopictus mosquitoes
por: Ledermann, Jeremy P, et al.
Publicado: (2017)

Chikungunya virus adaptation to Aedes albopictus mosquitoes does not correlate with acquisition of cholesterol dependence or decreased pH threshold for fusion reaction
por: Tsetsarkin, Konstantin A, et al.
Publicado: (2011)

IRES-driven Expression of the Capsid Protein of the Venezuelan Equine Encephalitis Virus TC-83 Vaccine Strain Increases Its Attenuation and Safety
por: Guerbois, Mathilde, et al.
Publicado: (2013)

Equine Polyclonal Antibodies Prevent Acute Chikungunya Virus Infection in Mice
por: Barker, Douglas, et al.
Publicado: (2023)

Rationally Attenuated Vaccines for Venezuelan Equine Encephalitis Protect Against Epidemic Strains with a Single Dose
por: Rossi, Shannan L., et al.
Publicado: (2020)

Adaptation of Enterovirus 71 to Adult Interferon Deficient Mice
por: Caine, Elizabeth A., et al.
Publicado: (2013)

IRES-Containing VEEV Vaccine Protects Cynomolgus Macaques from IE Venezuelan Equine Encephalitis Virus Aerosol Challenge
por: Rossi, Shannan L., et al.
Publicado: (2015)

Chikungunya: epidemiology
por: Petersen, Lyle R., et al.
Publicado: (2016)

Chikungunya Virus Vaccine Candidates with Decreased Mutational Robustness Are Attenuated In Vivo and Have Compromised Transmissibility
por: Carrau, Lucía, et al.
Publicado: (2019)

Utilization of an Eilat Virus-Based Chimera for Serological Detection of Chikungunya Infection
por: Erasmus, Jesse H., et al.
Publicado: (2015)

Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice
por: Caine, Elizabeth A., et al.
Publicado: (2015)

Genetic and Anatomic Determinants of Enzootic Venezuelan Equine Encephalitis Virus Infection of Culex (Melanoconion) taeniopus
por: Kenney, Joan L., et al.
Publicado: (2012)

A Rapid Immunization Strategy with a Live-Attenuated Tetravalent Dengue Vaccine Elicits Protective Neutralizing Antibody Responses in Non-Human Primates
por: Ambuel, Yuping, et al.
Publicado: (2014)

Lineage Divergence and Vector-Specific Adaptation Have Driven Chikungunya Virus onto Multiple Adaptive Landscapes
por: Chen, Rubing, et al.
Publicado: (2021)

Chikungunya Vaccine Candidates: Current Landscape and Future Prospects
por: Schmidt, Christin, et al.
Publicado: (2022)

Dual miRNA Targeting Restricts Host Range and Attenuates Neurovirulence of Flaviviruses
por: Tsetsarkin, Konstantin A., et al.
Publicado: (2015)

Expression of anti-chikungunya single-domain antibodies in transgenic Aedes aegypti reduces vector competence for chikungunya virus and Mayaro virus
por: Webb, Emily M., et al.
Publicado: (2023)

Chikungunya Virus–Vector Interactions
por: Coffey, Lark L., et al.
Publicado: (2014)

Construction and Evaluation of Recombinant Adenovirus Candidate Vaccines for Chikungunya Virus
por: Cao, Liang, et al.
Publicado: (2022)

Nowcasting the Spread of Chikungunya Virus in the Americas
por: Johansson, Michael A., et al.
Publicado: (2014)

High Rates of O’Nyong Nyong and Chikungunya Virus Transmission in Coastal Kenya
por: LaBeaud, A. Desiree, et al.
Publicado: (2015)

A Rodent Model of Chikungunya Virus Infection in RAG1 (-/-) Mice, with Features of Persistence, for Vaccine Safety Evaluation
por: Seymour, Robert L., et al.
Publicado: (2015)

IRE International Convention
por: Collective
Publicado: (1960)

4.4 Å cryo-EM structure of an enveloped alphavirus Venezuelan equine encephalitis virus
por: Zhang, Rui, et al.
Publicado: (2011)

Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus
por: Tsetsarkin, Konstantin A., et al.
Publicado: (2019)

Effects of Chikungunya virus immunity on Mayaro virus disease and epidemic potential
por: Webb, Emily M., et al.
Publicado: (2019)

LOOP IIId of the HCV IRES is essential for the structural rearrangement of the 40S-HCV IRES complex
por: Angulo, Jenniffer, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_crho42r5apl8ljt8kdi5nb5u6q